Through its business units or subsidiaries, The Trendlines Group partners with a number of bodies affiliated with the Government of Singapore.
In January 2017, SPRING Singapore, the enterprise development agency of Singapore’s Ministry of Trade and Industry, announced the allocation of a grant to Trendlines Medical Singapore of up to SGD2.2 million under its Incubator Development Program to support the incubator’s operating activities.
In March 2017, Trendlines Labs embarked on its first collaboration agreement with Singapore General Hospital (SGH), the flagship hospital of SingHealth, Singapore’s largest health care system. Within the framework of the collaboration agreement, which received financial support from the Singapore Israel Industrial Research and Development Foundation (SIIRD), the binational funding agency of Israel and Singapore, Trendlines Labs and SGH are conducting clinical trials to further the development of a stress urinary incontinence product invented and developed by Trendlines Labs.
In November 2017, Trendlines Medical Singapore established a partnership with Singapore’s National Healthcare Group (NHG), part of the Singapore Ministry of Health. Combining the clinical expertise of NHG health care professionals with the innovation and technological expertise of Trendlines and its affiliated companies, the partnership aims to identify unmet clinical needs and develop new technological solutions to address these needs for the local and global medical market.
